Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cinaciguat

Cinaciguat
Cinaciguat (BAY 58-2667) (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
Catalog No. T1984Cas No. 329773-35-5
Select Batch
Purity:99.82%
Contact us for more batch information

Resource Download

Cinaciguat

Catalog No. T1984Alias BAY 58-2667Cas No. 329773-35-5

Cinaciguat (BAY 58-2667) (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$40In Stock
5 mg$88In Stock
10 mg$148In Stock
25 mg$223In Stock
50 mg$308In Stock
100 mg$437In Stock
200 mg$597In Stock
1 mL x 10 mM (in DMSO)$110In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Cinaciguat"

Product Introduction

Bioactivity
Description
Cinaciguat (BAY 58-2667) (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
In vitro
Cinaciguat (10 μM) significantly enhances intracellular cGMP generation without exhibiting dose-dependent effects on cell contraction and calcium transients[2].
In vivo
Cinaciguat (10 mg/kg/day, p.o.) treatment in diabetic rats does not affect blood glucose levels but reduces water intake, alleviates diabetes mellitus-related oxidative stress, protects against alterations in the NO-sGC-cGMP-PKG signaling pathway, and reduces myocardium hypertrophy and apoptosis[1]. Cinaciguat (1-10-100 nM) induces concentration-dependent relaxations in strips from both WT and apo-sGC mice, but does not influence phasic activity induced by PGF2α in WT or apo-sGC strips[3].
Kinase Assay
HDAC Inhibition Assays: Purified HDACs are incubated with 1 mM carboxyfluorescein (FAM)-labeled acetylated peptide substrate and test compound for 17 h at 25 °C in HDAC assay buffer containing 100 mM HEPES (pH 7.5), 25 mM KCl, 0.1% BSA, and 0.01% Triton X-100. Reactions are terminated by the addition of buffer containing 0.078% SDS for a final SDS concentration of 0.05%. Substrate and product are separated electrophoretically using a Caliper LabChip 3000 system with blue laser excitation and green fluorescence detection (CCD2). The fluorescence intensity in the substrate and product peaks is determined using the Well Analyzer software on the Caliper system. The reactions are performed in duplicate for each sample. IC50 values are automatically calculated using the IDBS XLFit version 4.2.1 plug-in for Microsoft Excel and the XLFit 4-Parameter Logistic Model: ((A+((B_A)/1+((C/x)D)))), in which x is compound concentration, A and B are respectively the estimated minimum and maximum of percent inhibition, C is the inflection point, and D is the Hill slope of the sigmoidal curve. The standard errors of the IC50 values are automatically calculated using the IDBS XLFit version 4.2.1 plug-in for Microsoft Excel and the formula xf4_FitResultStdError.
AliasBAY 58-2667
Chemical Properties
Molecular Weight565.7
FormulaC36H39NO5
Cas No.329773-35-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (79.55 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7677 mL8.8386 mL17.6772 mL88.3861 mL
5 mM0.3535 mL1.7677 mL3.5354 mL17.6772 mL
10 mM0.1768 mL0.8839 mL1.7677 mL8.8386 mL
20 mM0.0884 mL0.4419 mL0.8839 mL4.4193 mL
50 mM0.0354 mL0.1768 mL0.3535 mL1.7677 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cinaciguat | purchase Cinaciguat | Cinaciguat cost | order Cinaciguat | Cinaciguat chemical structure | Cinaciguat in vivo | Cinaciguat in vitro | Cinaciguat formula | Cinaciguat molecular weight